Purchase Order HHSN272201400358P
Award Date 3/20/14
Potential Completion Date 3/31/14
Potential Value $9.2K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Damascus, MD 20872, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a part of the U.S. Department of Health and Human Services, to Aalto Bio Reagents Limited, a for-profit limited liability company based in Ireland. The award, with a firm fixed price of $3,935.00, is for the purchase of 5 units of AMBIS 1699473 AFFINITY PURIFIED SHEEP ANTI-HIV-1-GP120 ANTIBODY at a unit price of $787.00 per unit. The contract does not have a set-aside designation and...
- This federal contract award, valued at $499,879.67, was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services (HHS), to Southern Research Institute, a non-profit research organization. The contract is for the identification of lead compounds to inhibit HIV, as part of NIAID's broader "In Vitro Testing Resource for HIV Therapeutics and Topical Microbicides" program. The contract is a Delivery Order...
- This is a federal contract award from the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services, to Advanced Bioscience Laboratories, Inc. (ABL), a for-profit manufacturer of goods. The contract is for the production of HIV-1gp120 protein in support of NIAID's preclinical development program. The contract, which does not have a set-aside designation, has a ceiling value of $4,240,924.91 and an ultimate...
- The federal contract award, HHSN272201600008I|HHSN27200001, was granted by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services, to Advanced Bioscience Laboratories, Inc. (ABL), a for-profit manufacturer of goods. The contract is for $4,669,061.95 and is for quality assurance/quality control (QA/QC) services in support of the NIAID's Comprehensive Resources for HIV Microbicides and Biomedical Prevention...
- This is a federal contract award from the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services (HHS). The $128,312.76 cost-plus-fixed-fee contract was awarded to Southern Research Institute, a non-profit organization that provides research and development services, to develop new assays for HIV therapeutics and topical microbicides. The contract does not have a set-aside designation. Southern Research Institute...
- This contract award, with ID HHSN272201400892P, was issued by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Aalto Bio Reagents LIMITED, a for-profit limited liability company. The $3,935.00 firm fixed-price contract is for the purchase of an unspecified antibody product, with a completion date of September 15, 2014. The contract did not utilize any set-aside designations. Without additional information on the original...
- This federal contract award was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency under the Department of Health and Human Services. The contract, valued at $3,731,476.00, is for the NIAID Preclinical Development Support program, specifically to support the production and testing of ADC6-HIV GP140 and ADC7-HIV GP140. The prime contractor is Advanced Bioscience Laboratories, Inc. (ABL), a for-profit manufacturer of goods that specializes in the...
- This federal contract award was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a division of the U.S. Department of Health and Human Services, to Maple Leaf Medical HIV Research Collaborative Inc., a non-profit organization. The $30,600.00 firm fixed-price purchase order is for screening and interviewing 18 HIV-infected patients, including collecting medical history, blood samples, and specimen shipping. The contract does not have a set-aside designation. This award...
- This federal contract award was issued by the National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. Department of Health and Human Services (HHS), to Advanced Bioscience Laboratories, Inc. (ABL), a foreign-owned for-profit manufacturer of goods. The $616,640.51 cost-plus-fixed-fee contract, which is not set aside, supports the "OVINE MODEL AND VAGINAL MICROBIOME SUPPORT FOR HIV NONVACCINE BIOMEDICAL PREVENTION PRODUCT DEVELOPMENT" under NIAID's...
- This federal contract award, valued at $2,959,434.41, was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services, to Advanced Bioscience Laboratories, Inc. (ABL). The contract is for the synthesis and production of an HIV-1 envelope glycopeptide immunogen nanoparticle vaccine as part of NIAID's Preclinical Development Support program. This is a cost-plus-fixed-fee delivery order contract with an ultimate...